Related Experiment Videos
Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy
Kourosh Rezania1, Betul Gundogdu, Betty Soliven
1Department of Neurology, The University of Chicago, 5841 S. Maryland Ave/MC2030, Chicago, IL, 60637, USA. bsoliven@neurology.bsd.uchicago.edu
Frontiers in Bioscience : a Journal and Virtual Library
|February 10, 2004
Summary
Chronic inflammatory demyelinating polyneuropathy (CIDP) involves immune-mediated nerve damage. This review explores CIDP
Area of Science:
- Neuroimmunology
- Neurology
- Immunopathology
Background:
- Chronic inflammatory demyelinating polyneuropathy (CIDP) is a complex immune-mediated disorder affecting peripheral nerves.
- Its pathogenesis involves heterogeneous clinical and immunological factors, with both cellular and humoral immunity implicated.
Purpose of the Study:
- To review current knowledge on the immunopathogenesis of CIDP.
- To provide insights from animal models relevant to CIDP.
Main Methods:
- Review of existing literature on CIDP immunopathogenesis.
- Analysis of findings from animal models of demyelinating neuropathies.
Main Results:
- CIDP pathogenesis involves T cell activation, blood-nerve barrier breakdown, and intraneural inflammation with macrophage recruitment.
- Cytokines and toxic factors secreted during inflammation damage myelin and axons.
- Antibody production against nerve/myelin antigens by B cells, induced by T cells, is also a key factor.
Conclusions:
- CIDP results from a complex interplay of immune factors, including T cells, B cells, macrophages, and antibodies.
- Understanding the precise initiating antigens and T cell activation sites remains crucial.
- Animal models offer valuable insights into CIDP mechanisms and potential therapeutic targets.